全市学校流感疫苗接种回顾性队列研究
本研究评估了加州奥克兰市在超过102所小学实施的全市学校流感疫苗接种(SLIV)项目的效果。采用回顾性队列设计,对KPNC成员进行差异中的差异分析,发现干预期间干预点疫苗接种率高出8-11%,学龄儿童奥司他韦处方减少,65岁以上成人MAARI降低。结论提示SLIV可能对老年人产生间接保护效应。
要点
- 全市SLIV项目使干预点疫苗接种率较对照点提高8-11%。
- 学龄儿童中SLIV与奥司他韦处方每千人降低相关(2015-16年DID -3.5,2016-17年-4.0)。
- 65岁以上成人中SLIV与MAARI每千人降低相关(三个流感季DID分别为-13.2、-21.5、-13.0)。
核心结论
- 全市学校流感疫苗接种干预与疫苗接种覆盖率升高相关,并与学龄儿童奥司他韦处方减少及65岁以上成人MAARI降低相关。
- 结果提示SLIV可能对老年人产生间接保护效应。
研究设计与样本
- 回顾性队列研究,纳入2011年9月至2017年8月居住于干预点或经多变量匹配的对照点的KPNC全年龄段成员。
- 干预点为加州奥克兰市超过102所小学实施的全市SLIV项目。
- 采用广义线性模型估计2014-15、2015-16和2016-17三个流感季的差异中的差异(DID),并调整种族、民族、年龄、性别、健康计划和语言。
主要发现
- 干预前两站点成员特征相似。
- 干预期间,干预点经KPNC或SLIV项目接种流感疫苗的成员比例较对照点高8-11%。
- 学龄儿童中,SLIV与奥司他韦处方每千人降低相关(2015-16年DID -3.5,95%CI -5.5至-1.5;2016-17年DID -4.0,95%CI -6.5至-1.6),与其他结局无显著关联。
- 65岁以上成人中,SLIV与MAARI每千人降低相关(2014-15年DID -13.2,95%CI -23.2至-3.2;2015-16年DID -21.5,95%CI -31.1至-11.9;2016-17年DID -13.0,95%CI -23.2至-2.9)。
- 成人中其他结局的显著关联较少。
临床怎么用
- 全市学校流感疫苗接种项目可作为提高社区疫苗接种覆盖率、减少学龄儿童奥司他韦使用的策略。
- 该项目可能通过间接效应降低老年人流感相关就医,对老年人群产生保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We measured the effectiveness of a city-wide school-located influenza vaccination (SLIV) program implemented in over 102 elementary schools in Oakland, California. METHODS: We conducted a retrospective cohort study among Kaiser Permanente Northern California (KPNC) members of all ages residing in either the intervention or a multivariate-matched comparison site from September 2011 - August 2017. Outcomes included medically attended acute respiratory illness (MAARI), influenza hospitalization, and Oseltamivir prescriptions. We estimated difference-in-differences (DIDs) in 2014-15, 2015-16, and 2016-17 using generalized linear models and adjusted for race, ethnicity, age, sex, health plan, and language. RESULTS: Pre-intervention member characteristics were similar between sites. The proportion of KPNC members vaccinated for influenza by KPNC or the SLIV program was 8-11% higher in the intervention site than the comparison site during the intervention period. Among school-aged children, SLIV was associated with lower Oseltamivir prescriptions per 1,000 (DIDs: -3.5 (95% CI -5.5, -1.5) in 2015-16; -4.0 (95% CI -6.5, -1.6) in 2016-17) but not with other outcomes. SLIV was associated with lower MAARI per 1,000 in adults 65 + years (2014-15: -13.2, 95% CI -23.2, -3.2; 2015-16: -21.5, 95% CI -31.1, -11.9; 2016-17: -13.0, 95% CI -23.2, -2.9). There were few significant associations with other outcomes among adults. CONCLUSIONS: A city-wide SLIV intervention was associated with higher influenza vaccination coverage, lower Oseltamivir prescriptions in school-aged children, and lower MAARI among people over 65 years, suggesting possible indirect effects of SLIV among older adults.
引用
- Benjamin-Chung J, Arnold BF, Mishra K, et al. City-wide school-located influenza vaccination: A retrospective cohort study. Vaccine. 2021. PMID: 34535312. doi:10.1016/j.vaccine.2021.08.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。